HEADER MEMBRANE PROTEIN 21-AUG-19 6KR8 TITLE STRUCTURE OF THE BETA2 ADRENERGIC RECEPTOR IN THE FULL AGONIST BOUND TITLE 2 STATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA 2 ADRENERGIC RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_TAXID: 9606; SOURCE 4 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS G-PROTEIN COUPLED RECEPTOR, B2AR, FULL AGONIST, MEMBRANE PROTEIN EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR S.IMAI,I.SHIMADA REVDAT 4 13-NOV-24 6KR8 1 REMARK REVDAT 3 08-APR-20 6KR8 1 JRNL REVDAT 2 05-FEB-20 6KR8 1 JRNL REVDAT 1 29-JAN-20 6KR8 0 JRNL AUTH S.IMAI,T.YOKOMIZO,Y.KOFUKU,Y.SHIRAISHI,T.UEDA,I.SHIMADA JRNL TITL STRUCTURAL EQUILIBRIUM UNDERLYING LIGAND-DEPENDENT JRNL TITL 2 ACTIVATION OF BETA2-ADRENORECEPTOR. JRNL REF NAT.CHEM.BIOL. V. 16 430 2020 JRNL REFN ESSN 1552-4469 JRNL PMID 31959965 JRNL DOI 10.1038/S41589-019-0457-5 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS, X-PLOR NIH REMARK 3 AUTHORS : BRUNGER A. T. ET.AL. (CNS), SCHWIETERS, KUSZEWSKI, REMARK 3 TJANDRA AND CLORE (X-PLOR NIH) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6KR8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 29-AUG-19. REMARK 100 THE DEPOSITION ID IS D_1300013262. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : 0 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 20 MM HEPES, 100 UM [2,3,3 REMARK 210 -2H,15N]-LEU BETA 2 ADRENERGIC REMARK 210 RECEPTOR (A59C-MTSL), 95% H2O/5% REMARK 210 D2O; 20 MM HEPES, 100 UM [2,3,3- REMARK 210 2H,15N]-LEU BETA 2 ADRENERGIC REMARK 210 RECEPTOR (A59C-MTSL), 1 MM REMARK 210 ASCORBATE, 95% H2O/5% D2O; 20 MM REMARK 210 HEPES, 100 UM [2,3,3-2H,15N]-LEU REMARK 210 BETA 2 ADRENERGIC RECEPTOR REMARK 210 (T136C-MTSL), 95% H2O/5% D2O; 20 REMARK 210 MM HEPES, 100 UM [2,3,3-2H,15N]- REMARK 210 LEU BETA 2 ADRENERGIC RECEPTOR REMARK 210 (T136C-MTSL), 1 MM ASCORBATE, 95% REMARK 210 H2O/5% D2O; 20 MM HEPES, 100 UM REMARK 210 [2,3,3-2H,15N]-LEU BETA 2 REMARK 210 ADRENERGIC RECEPTOR (N148C-MTSL), REMARK 210 95% H2O/5% D2O; 20 MM HEPES, REMARK 210 100 UM [2,3,3-2H,15N]-LEU BETA 2 REMARK 210 ADRENERGIC RECEPTOR (N148C-MTSL), REMARK 210 1 MM ASCORBATE, 95% H2O/5% D2O; REMARK 210 20 MM HEPES, 100 UM [2,3,3-2H, REMARK 210 15N]-LEU BETA 2 ADRENERGIC REMARK 210 RECEPTOR (L266C-MTSL), 95% H2O/5% REMARK 210 D2O; 20 MM HEPES, 100 UM [2,3,3- REMARK 210 2H,15N]-LEU BETA 2 ADRENERGIC REMARK 210 RECEPTOR (L266C-MTSL), 1 MM REMARK 210 ASCORBATE, 95% H2O/5% D2O; 20 MM REMARK 210 HEPES, 100 UM [2,3,3-2H,15N]-LEU REMARK 210 BETA 2 ADRENERGIC RECEPTOR REMARK 210 (I334C-MTSL), 95% H2O/5% D2O; 20 REMARK 210 MM HEPES, 100 UM [2,3,3-2H,15N]- REMARK 210 LEU BETA 2 ADRENERGIC RECEPTOR REMARK 210 (I334C-MTSL), 1 MM ASCORBATE, 95% REMARK 210 H2O/5% D2O; 20 MM HEPES, 100 UM REMARK 210 [2,3,3-2H,15N]-LEU BETA 2 REMARK 210 ADRENERGIC RECEPTOR (I334C-MTSL), REMARK 210 95% H2O/5% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE III REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : TOPSPIN REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 500 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 465 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 MODELS 1-10 REMARK 465 RES C SSSEQI REMARK 465 GLY A 24 REMARK 465 THR A 25 REMARK 465 GLN A 26 REMARK 465 GLN A 27 REMARK 465 ARG A 28 REMARK 465 ASP A 29 REMARK 465 ALA A 342 REMARK 465 ARG A 343 REMARK 465 ARG A 344 REMARK 465 SER A 345 REMARK 465 SER A 346 REMARK 465 VAL A 347 REMARK 465 LYS A 348 REMARK 465 ALA A 349 REMARK 465 HIS A 350 REMARK 465 HIS A 351 REMARK 465 HIS A 352 REMARK 465 HIS A 353 REMARK 465 HIS A 354 REMARK 465 HIS A 355 REMARK 465 HIS A 356 REMARK 465 HIS A 357 REMARK 465 HIS A 358 REMARK 465 HIS A 359 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 THR A 56 -46.95 -141.98 REMARK 500 1 CYS A 59 -41.26 -173.56 REMARK 500 1 ARG A 63 -13.65 77.85 REMARK 500 1 ALA A 134 48.65 -75.45 REMARK 500 1 CYS A 136 -132.38 76.39 REMARK 500 1 SER A 137 160.37 72.50 REMARK 500 1 LYS A 140 -47.16 167.16 REMARK 500 1 THR A 146 173.53 61.22 REMARK 500 1 CYS A 148 -78.20 -149.08 REMARK 500 1 SER A 165 -77.15 -115.80 REMARK 500 1 HIS A 172 31.48 70.76 REMARK 500 1 GLU A 237 115.44 -171.46 REMARK 500 1 PHE A 240 87.35 59.81 REMARK 500 1 GLN A 243 -72.92 170.62 REMARK 500 1 ASN A 244 160.70 179.73 REMARK 500 1 GLU A 249 -39.10 -152.32 REMARK 500 1 ASP A 251 -169.27 52.30 REMARK 500 1 THR A 254 158.23 67.30 REMARK 500 1 HIS A 256 -69.93 76.56 REMARK 500 1 ARG A 259 -179.46 61.25 REMARK 500 1 ALA A 265 -72.55 -50.33 REMARK 500 1 TRP A 286 -58.75 139.13 REMARK 500 1 ILE A 325 -63.92 -95.28 REMARK 500 1 SER A 327 40.76 -88.29 REMARK 500 2 THR A 56 85.56 45.15 REMARK 500 2 CYS A 59 17.10 58.00 REMARK 500 2 CYS A 136 60.07 37.97 REMARK 500 2 LEU A 145 126.60 80.22 REMARK 500 2 THR A 146 96.26 -63.75 REMARK 500 2 LYS A 147 -162.56 49.02 REMARK 500 2 LYS A 149 11.34 -157.37 REMARK 500 2 ALA A 150 -27.56 72.53 REMARK 500 2 SER A 165 -77.15 -115.80 REMARK 500 2 HIS A 172 31.48 70.76 REMARK 500 2 GLU A 237 135.02 178.81 REMARK 500 2 VAL A 245 91.77 63.02 REMARK 500 2 GLN A 247 -40.26 -178.54 REMARK 500 2 GLN A 250 59.28 74.36 REMARK 500 2 HIS A 258 -56.34 165.76 REMARK 500 2 ARG A 260 -65.87 79.06 REMARK 500 2 ALA A 265 -72.57 -50.32 REMARK 500 2 TRP A 286 -59.41 138.04 REMARK 500 2 ILE A 325 -64.70 -98.41 REMARK 500 2 SER A 327 81.72 -57.60 REMARK 500 3 ILE A 55 43.68 -103.30 REMARK 500 3 ALA A 57 84.74 50.04 REMARK 500 3 PHE A 61 83.31 58.12 REMARK 500 3 GLU A 62 -158.73 -61.50 REMARK 500 3 ARG A 63 -50.64 77.22 REMARK 500 3 PHE A 133 -72.37 -24.40 REMARK 500 REMARK 500 THIS ENTRY HAS 211 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 36284 RELATED DB: BMRB REMARK 900 STRUCTURE OF THE BETA2 ADRENERGIC RECEPTOR IN THE FULL AGONIST REMARK 900 BOUND STATE DBREF 6KR8 A 24 359 PDB 6KR8 6KR8 24 359 SEQRES 1 A 336 GLY THR GLN GLN ARG ASP GLU VAL TRP VAL VAL GLY MET SEQRES 2 A 336 GLY ILE VAL MET SER LEU ILE VAL LEU ALA ILE VAL PHE SEQRES 3 A 336 GLY ASN VAL LEU VAL ILE THR ALA ILE CYS LYS PHE GLU SEQRES 4 A 336 ARG LEU GLN THR VAL THR ASN TYR PHE ILE THR SER LEU SEQRES 5 A 336 ALA VAL ALA ASP LEU VAL MET GLY LEU ALA VAL VAL PRO SEQRES 6 A 336 PHE GLY ALA ALA HIS ILE LEU THR LYS THR TRP THR PHE SEQRES 7 A 336 GLY ASN PHE TRP CYS GLU PHE TRP THR SER ILE ASP VAL SEQRES 8 A 336 LEU CYS VAL THR ALA SER ILE TRP THR LEU CYS VAL ILE SEQRES 9 A 336 ALA VAL ASP ARG TYR PHE ALA ILE CYS SER PRO PHE LYS SEQRES 10 A 336 TYR GLN SER LEU LEU THR LYS CYS LYS ALA ARG VAL ILE SEQRES 11 A 336 ILE LEU MET VAL TRP ILE VAL SER GLY LEU THR SER PHE SEQRES 12 A 336 LEU PRO ILE GLN MET HIS TRP TYR ARG ALA THR HIS GLN SEQRES 13 A 336 GLU ALA ILE ASN CYS TYR ALA GLU GLU THR CYS CYS ASP SEQRES 14 A 336 PHE PHE THR ASN GLN ALA TYR ALA ILE ALA SER SER ILE SEQRES 15 A 336 VAL SER PHE TYR VAL PRO LEU VAL ILE MET VAL PHE VAL SEQRES 16 A 336 TYR SER ARG VAL PHE GLN GLU ALA LYS ARG GLN LEU GLN SEQRES 17 A 336 LYS ILE ASP LYS SER GLU GLY ARG PHE HIS VAL GLN ASN SEQRES 18 A 336 VAL SER GLN VAL GLU GLN ASP GLY ARG THR GLY HIS GLY SEQRES 19 A 336 HIS ARG ARG SER SER LYS PHE ALA CYS LYS GLU HIS LYS SEQRES 20 A 336 ALA LEU LYS THR LEU GLY ILE ILE MET GLY THR PHE THR SEQRES 21 A 336 LEU CYS TRP LEU PRO PHE PHE ILE VAL ASN ILE VAL HIS SEQRES 22 A 336 VAL ILE GLN ASP ASN LEU ILE ARG LYS GLU VAL TYR ILE SEQRES 23 A 336 LEU LEU ASN TRP ILE GLY TYR VAL ASN SER GLY PHE ASN SEQRES 24 A 336 PRO LEU ILE TYR SER ARG SER PRO ASP PHE ARG CYS ALA SEQRES 25 A 336 PHE GLN GLU LEU LEU ALA ALA ARG ARG SER SER VAL LYS SEQRES 26 A 336 ALA HIS HIS HIS HIS HIS HIS HIS HIS HIS HIS HELIX 1 AA1 VAL A 31 ILE A 55 1 25 HELIX 2 AA2 THR A 66 ALA A 85 1 20 HELIX 3 AA3 ALA A 85 LYS A 97 1 13 HELIX 4 AA4 GLY A 102 PHE A 133 1 32 HELIX 5 AA5 LYS A 140 LEU A 145 1 6 HELIX 6 AA6 LYS A 149 THR A 164 1 16 HELIX 7 AA7 SER A 165 MET A 171 1 7 HELIX 8 AA8 HIS A 178 GLU A 187 1 10 HELIX 9 AA9 ASN A 196 PHE A 208 1 13 HELIX 10 AB1 PHE A 208 SER A 236 1 29 HELIX 11 AB2 ARG A 260 CYS A 285 1 26 HELIX 12 AB3 TRP A 286 GLN A 299 1 14 HELIX 13 AB4 ARG A 304 TYR A 326 1 23 HELIX 14 AB5 SER A 329 ALA A 341 1 13 SSBOND 1 CYS A 106 CYS A 191 1555 1555 2.04 SSBOND 2 CYS A 184 CYS A 190 1555 1555 2.04 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1